Search Result "SGLT-2i agents"
Hormonal, Metabolic and Hemodynamic Adaptations to Glycosuria in Type 2 Diabetes Patients Treated with Sodium-Glucose Co-Transporter Inhibitors
Journal: Current Diabetes Reviews
Volume: 15 Issue: 4 Year: 2019 Page: 314-327
Author(s): Eugenio Cersosimo,John M. Miles
Novel Antidiabetic Agents: Cardiovascular and Safety Outcomes
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 46 Year: 2020 Page: 5911-5932
Author(s): Gerasimos Siasos,Evanthia Bletsa,Panagiota K. Stampouloglou,Stavroula A. Paschou,Evangelos Oikonomou,Vasiliki Tsigkou,Alexios S. Antonopoulos,Manolis Vavuranakis,Dimitrios Tousoulis
Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome Trials
Journal: Current Diabetes Reviews
Volume: 16 Issue: 9 Year: 2020 Page: 917-921
Author(s): Samit Ghosal,Binayak Sinha
Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18 Issue: 2 Year: 2018 Page: 94-103
Author(s): Konstantinos Avranas,Konstantinos Imprialos,Konstantinos Stavropoulos,Georgios Lales,Alexandos Manafis,Anastasia Skalkou,Lars Kihm
Pharmacological Management of Diabetic Nephropathy
Journal: Current Vascular Pharmacology
Volume: 18 Issue: 2 Year: 2020 Page: 139-147
Author(s): Vasilios Papademetriou,Sofia Alataki,Konstantinos Stavropoulos,Christodoulos Papadopoulos,Kostas Bakogiannis,Kostas Tsioufis
Recent Developments in Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors as a Valuable Tool in the Treatment of Type 2 Diabetes Mellitus
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 3 Year: 2020 Page: 170-182
Author(s): Shubham Kumar,Gopal L. Khatik,Amit Mittal
Metabolic Complications and Kidney Transplantation: Focus on Glycaemia and Dyslipidaemia
Journal: Current Vascular Pharmacology
Volume: 18 Issue: 3 Year: 2020 Page: 273-281
Author(s): Panagiotis Anagnostis,Stavroula Î. Paschou,Eleftherios Spartalis,Gerardo Sarno,Paride De Rosa,Giovanna Muscogiuri
Diabetes in Menopause: Risks and Management
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 6 Year: 2019 Page: 556-563
Author(s): Stavroula Î. Paschou,Panagiotis Anagnostis,Dimitra I. Pavlou,Andromachi Vryonidou,Dimitrios G. Goulis,Irene Lambrinoudaki
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success inCOVID-19?
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 15 Year: 2024 Page: 1149-1156
Author(s):
Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 3 Year: 2018 Page: 276-288
Author(s): Konstantinos Imprialos,Konstantinos Stavropoulos,Sofia Bouloukou,Georgios Kerpiniotis,Asterios Karagiannis,Michael Doumas